The caregiver role in thromboprophylaxis management in atrial fibrillation: A literature review

@article{Ferguson2015TheCR,
  title={The caregiver role in thromboprophylaxis management in atrial fibrillation: A literature review},
  author={Caleb Ferguson and Sally C Inglis and Phillip J. Newton and Sandy Middleton and Peter S. Macdonald and Patricia M. Davidson},
  journal={European Journal of Cardiovascular Nursing},
  year={2015},
  volume={14},
  pages={107 - 98}
}
Background: Atrial fibrillation is a common arrhythmia and a risk factor for adverse events including stroke. People living with atrial fibrillation are commonly elderly and have multiple comorbidities. The role of a caregiver in supporting the individual to manage a chronic and complex condition has received limited attention. Objectives: This review aims to summarize available information on the caregiver role in atrial fibrillation, specifically in promoting adherence to thromboprophylaxis… 
Multi-morbidity, frailty and self-care: important considerations in treatment with anticoagulation drugs. Outcomes of the AFASTER study
TLDR
Multi-morbidity, frailty and self-care to be important considerations in thromboprophylaxis are highlighted and shared decision-making with patients and caregivers offers the potential to improve treatment knowledge, adherence and outcomes in patients with complex care needs.
Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation
TLDR
Cognitive impairment is an independent determinant of compliance with pharmacological therapy in elderly patients with atrial fibrillation and lower adherence, beyond the assessment of cognitive function, is related to the age of patients.
Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives
TLDR
Nurses can help patients and caregivers to understand complex anticoagulant risk-benefit information, and act as a patient advocate when making complex stroke prevention decisions, and challenge these treatment barriers to optimise therapy.
Partnering with patients in shared decision-making for stroke prevention in atrial fibrillation
  • C. Ferguson, J. Hendriks
  • Medicine
    European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology
  • 2017
TLDR
Before patients and caregivers are ready to participate in decision-making processes, it is vital that they are comprehensively educated on both their condition and the available therapeutic approaches to stroke prevention in AF.
Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians
  • J. Foody
  • Medicine
    Clinical interventions in aging
  • 2017
TLDR
Clinical trial data are now available, and real-world data are emerging, to illustrate the relative merits of the non-vitamin K antagonist oral anticoagulant agents in elderly populations and to suggest some subgroups of older patients who may be more suitable candidates for particular agents.
Impact of body mass index on mortality and hospitalisation of patients with atrial fibrillation
TLDR
Overweight and obesity were not associated with survival in patients with chronic atrial fibrillation but were associated with more frequent hospital care and prolonged stay.
Education and practice gaps on atrial fibrillation and anticoagulation: a survey of cardiovascular nurses
TLDR
There is scope for improvement for cardiovascular nurses in ANZ in relation to AF and anticoagulation knowledge and practice, and perceived barriers and enablers to anticogeulation in AF are described.
Burden of Providing Informal Care for Patients with Atrial Fibrillation.
TLDR
Caring for a patient with AF is associated with substantial objective and subjective burden, but also provides fulfillment from being able to care for a loved one.
Dancing with atrial fibrillation – How arrhythmia affects everyday life of family members: A qualitative study
TLDR
There is a need for further research of ways to support the family members of patients with AF, as AF had a very significant impact on the patients’ family members, forcing them to reconstruct their daily lives.
An mHealth intervention to improve nurses’ atrial fibrillation and anticoagulation knowledge and practice: the EVICOAG study
  • C. Ferguson, L. Hickman, +4 authors B. Bajorek
  • Medicine
    European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology
  • 2019
TLDR
The EVICOAG intervention improved nurses’ knowledge of atrial fibrillation and anticoagulation, and influenced their uptake and use of stroke and bleeding risk assessment tools in clinical practice.
...
1
2
3
...

References

SHOWING 1-10 OF 80 REFERENCES
Atrial fibrillation: stroke prevention in focus.
TLDR
A review of the epidemiology of AF and stroke, stroke and bleeding risk, assessment tools and evidence based treatments for the prevention of stroke in AF including the use of, novel anti-thrombin agents is provided.
Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation.
TLDR
This model identifies an adherence process that can guide opportunities for effective interventions, such as educational and behavioral programs targeted at these processes, to improve patient adherence to OA medication.
Warfarin Therapy for Atrial Fibrillation in the Elderly
TLDR
Elderly patients with high stroke risk achieved therapeutic INR responses, however, those with significant cognitive or functional impairment require caregiver support and special consideration for anticoagulation management.
Underuse of oral anticoagulants in atrial fibrillation: a systematic review.
TLDR
The underuse of oral anticoagulation therapy for real-world atrial fibrillation patients with an elevated risk of stroke is demonstrated, highlighting the need for improved therapies for stroke prevention in atrialfibrillation.
A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice.
TLDR
The viewpoint regarding optimized AF management is presented by comprehensively addressing the main goals to be achieved, the related requirements for AF management programmes to achieve those goals, the position that nurses should have an important coordinating role in such programmes; and which outcomes should be targeted to evaluate effective deployment.
A review of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation.
TLDR
Judicious use of warfarin, tailored to individual stroke risk, seems to be a reasonable policy, and it is recommended for medium-risk patients unless their risk of bleeding is high or their quality of life while taking warFarin would be poor.
Caregiver assistance among Medicare beneficiaries with atrial fibrillation and factors associated with anticoagulant treatment.
TLDR
Logistic regression found that higher Charlson Comorbidity Index scores, difficulty in obtaining necessary health care, older age, being widowed, a history of psychiatric disorders, and being underweight decreased the likelihood of receiving anticoagulant therapy.
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study.
TLDR
Physicians' and patients' thresholds for how much reduction in risk of stroke is necessary and how much risk of excess bleeding is acceptable with antithrombotic treatment in people with atrial fibrillation are determined and compared.
Living With Atrial Fibrillation: A Qualitative Study
TLDR
Themes were identified that reveal experiences of living with recurrent symptomatic AF over time and how AF may diminish QOL and how interventions to improve QOL need to be developed and tested.
Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
This chapter about antithrombotic therapy in atrial fibrillation (AF) is part of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Grade 1
...
1
2
3
4
5
...